The Cell-CT 3-dimensional cell imaging technology platform enables the detection of lung cancer using the noninvasive LuCED sputum test

Cancer Cytopathology

Volumn 123, Issue 9, 2015, Pages 512-523

  Meyer, Michael G ^a   Hayenga, Jon W ^a   Neumann, Thomas ^a   Katdare, Rahul ^a   Presley, Chris ^a   Steinhauer, David E ^a   Bell, Timothy M ^a   Lancaster, Christy A ^a   Nelson, Alan C ^a  

^a Nortis Inc   (United States)

Author keywords

Cell CT; dysplasia; induced sputum; LuCED; lung cancer; lung cancer screening; sensitivity; specificity; spontaneous sputum; sputum cytology

Indexed keywords

ALGORITHM; BRONCHUS MUCOSA; CANCER CELL; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PATIENT; CANCER SCREENING; CANCER SURVIVAL; CELL STRUCTURE; CLASSIFIER; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; CRYOPRESERVATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC EQUIPMENT; EARLY DIAGNOSIS; EMBEDDING; EPITHELIUM CELL; FALSE POSITIVE RESULT; FLUORESCENCE ACTIVATED CELL SORTING; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; IMAGING SOFTWARE; LUNG CANCER; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RADIATION DOSE; REFERENCE VALUE; REVIEW; SENSITIVITY AND SPECIFICITY; SPUTUM CYTODIAGNOSIS; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; WAFER TEST; COMPUTER ASSISTED DIAGNOSIS; CYTODIAGNOSIS; CYTOLOGY; EARLY CANCER DIAGNOSIS; FEMALE; LUNG TUMOR; MALE; PATHOLOGY; PROCEDURES; RADIOGRAPHY; SPECIMEN HANDLING; SPUTUM;

CRYOPRESERVATION; CYTODIAGNOSIS; EARLY DETECTION OF CANCER; EPITHELIAL CELLS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LUNG NEOPLASMS; MALE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84951960258     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21576     Document Type: Review

References (23)

1. National Cancer Institute. The National Cancer Act of 1971. Available at: http://legislative.cancer.gov/history/phsa/1971. Accessed March 19, 2015.
2. Jemal A, Siegel R, Ward E, et al., Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
3. National Lung Screening Trial Research Team, Aberle D, Adams A, et al., Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
4. Mulcahy N,. It's final: CMS to cover lung cancer screening. Available at: http://www.medscape.com/viewarticle/839363. Accessed March 19, 2015.
5. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet C,. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008; 9: 649-656.
6. Yurkiewicz S,. New lung Ca screening criteria reduce false positives. Available at: http://www.medpagetoday.com/Pulmonology/Lung Cancer/49940. Accessed March 19, 2015.
7. Schreiber G, McCrory D,. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest. 2003; 123 (suppl 1): 115S-128S.
8. Bocking A, Biesterfeld S, Chatelain R, Gien-Gerlach G, Esser E,. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum: sensitivity and specificity of an alternative to routine cytology. Acta Cytol. 1992; 36: 37-47.
9. Neumann T, Meyer M, Patten F, et al., Premalignant and malignant cells in sputum from lung cancer patients. Cancer (Cancer Cytopathol). 2009; 117: 473-481.
10. Paggiaro P, Chanez P, Holz O, et al., Sputum induction. Eur Respir J Suppl. 2002; 20: 3S-8S.
11. Pedersen B, Brons M, Holm K, Pedersen D, Lund C,. The value of provoked expectoration in obtaining sputum samples for cytologic investigation. A prospective, consecutive and controlled investigation of 134 patients. Acta Cytol. 1985; 29: 750-752.
12. Fauver M, Seibel E, Rahn JR, et al., Three-dimensional imaging of single isolated cell nuclei using optical projection tomography. Opt Express. 2005; 13: 4210-4223.
13. Deans SR,. The Radon Transform and Some of Its Applications. New York: Dover Publishers; 2007.
14. Dartmouth University. Cilia and flagella. Available at: http://www.dartmouth.edu/ ∼cbbc/courses/bio15/2004W/slides/L13.pdf. Accessed March 19. 2015.
15. Weerakkody Y, Di Muzio B,. Maximum intensity projection (MIP). Available at: http://radiopaedia.org/articles/maximum-intensity-projection-mip. Accessed March 19, 2015.
16. Schapire R, Freund Y,. Boosting, Foundations and Algorithms. Cambridge, MA: MIT Press, 2012.
17. Breiman L,. Random forests. Mach Learn. 2001; 45: 5-32.
18. Meyer M, Patten F, Presley C, Neumann T, Nelson A,. Three-dimensional cellular morphometry: a new horizon for cytology and cancer detection. J Am Soc Cytopathol. 2012; 1: 6-7.
19. Meyer M, Fauver M, Rahn JR, et al., Automated cell analysis in 2D and 3D: a comparative study. Pattern Recognition. 2009; 42 (1): 141-146.
20. Clopper C, Pearson E,. The use of confidence fiducial limits illustrated in the case of the binomial. Biometrika. 1934; 26: 404-413.
21. Geisser S,. Predictive Inference. New York: Chapman and Hall; 1993.
22. Mody D,. Defining adequacy in nongynecologic cytology. Available at: http://www.cap.org/apps//cap.portal?-nfpb=true&cntvwrPtlt-actionOverride=%2Fportlets%2FcontentViewer%2Fshow&-windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=cap-today%2Fpap-ngc%2FNGC0803-adequacy.html&
23. Meyer M, Katdare R, Presley C, et al., Early detection of lung cancer based on 3-dimensional, morphometric analysis of cells from sputum. J Clin Oncol. 2014; 32: 5s.